M. Dianne Murphy

931 total citations
19 papers, 646 citations indexed

About

M. Dianne Murphy is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Dianne Murphy has authored 19 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 10 papers in Economics and Econometrics and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Dianne Murphy's work include Pharmaceutical studies and practices (11 papers), Pharmaceutical Economics and Policy (9 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). M. Dianne Murphy is often cited by papers focused on Pharmaceutical studies and practices (11 papers), Pharmaceutical Economics and Policy (9 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). M. Dianne Murphy collaborates with scholars based in United States, United Kingdom and Thailand. M. Dianne Murphy's co-authors include Robert M. Califf, Jennifer S. Li, Daniel K. Benjamin, Debbie Avant, P. Brian Smith, Eric L. Eisenstein, William Rodriguez, Lisa L. Mathis, Carissa M. Baker‐Smith and Barry Mangum and has published in prestigious journals such as JAMA, PEDIATRICS and Hypertension.

In The Last Decade

M. Dianne Murphy

18 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Dianne Murphy United States	14	426	232	74	69	69	19	646
Debbie Avant United States	11	489 1.1×	175 0.8×	94 1.3×	24 0.3×	51 0.7×	16	607
Alessandra Atzei Italy	10	384 0.9×	48 0.2×	74 1.0×	17 0.2×	47 0.7×	16	573
John van den Anker United States	12	402 0.9×	33 0.1×	50 0.7×	29 0.4×	252 3.7×	51	850
L T W de Jong-van den Berg Netherlands	13	179 0.4×	37 0.2×	63 0.9×	28 0.4×	187 2.7×	24	670
Robert J. Cluxton United States	11	58 0.1×	64 0.3×	77 1.0×	95 1.4×	31 0.4×	25	459
Martin Duerden United Kingdom	12	89 0.2×	197 0.8×	106 1.4×	34 0.5×	66 1.0×	32	518
Kristin M. Richards United States	14	117 0.3×	90 0.4×	97 1.3×	16 0.2×	44 0.6×	42	691
Andreea Farcaș Romania	11	84 0.2×	80 0.3×	27 0.4×	61 0.9×	20 0.3×	41	549
Donald G. Pittman United States	8	66 0.2×	168 0.7×	44 0.6×	189 2.7×	68 1.0×	11	674
Lisa L. Mathis United States	7	245 0.6×	107 0.5×	46 0.6×	13 0.2×	78 1.1×	9	341

Countries citing papers authored by M. Dianne Murphy

Since Specialization

Citations

This map shows the geographic impact of M. Dianne Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dianne Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dianne Murphy more than expected).

Fields of papers citing papers by M. Dianne Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dianne Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dianne Murphy. The network helps show where M. Dianne Murphy may publish in the future.

Co-authorship network of co-authors of M. Dianne Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dianne Murphy. A scholar is included among the top collaborators of M. Dianne Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dianne Murphy. M. Dianne Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Buschman, John, et al.. (2023). Cutting the Gordian (workload) Knot? Adding data services to academic library public services. The Journal of Academic Librarianship. 49(6). 102801–102801.

Temeck, Jean, et al.. (2016). A Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA From 2007–2013. Therapeutic Innovation & Regulatory Science. 50(5). 639–647. 8 indexed citations

Murphy, M. Dianne, et al.. (2014). Impact of Pediatric Exclusivity on Drug Labeling and Demonstrations of Efficacy. PEDIATRICS. 134(2). e512–e518. 67 indexed citations

Dunne, Julia, M. Dianne Murphy, & William Rodriguez. (2012). The Globalization of Pediatric Clinical Trials. PEDIATRICS. 130(6). e1583–e1591. 14 indexed citations

Baker‐Smith, Carissa M., et al.. (2010). Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials. Clinical Pharmacology & Therapeutics. 87(6). 668–671. 23 indexed citations

Dunne, Julia, et al.. (2010). Globalization Facilitates Pediatric Drug Development in the 21 st Century. Drug Information Journal. 44(6). 757–765. 2 indexed citations

Benjamin, Daniel K., P. Brian Smith, Meng Sun, et al.. (2009). Safety and Transparency of Pediatric Drug Trials. Archives of Pediatrics and Adolescent Medicine. 163(12). 1080–6. 50 indexed citations

Baker‐Smith, Carissa M., Daniel K. Benjamin, Henry G. Grabowski, et al.. (2008). The economic returns of pediatric clinical trials of antihypertensive drugs. American Heart Journal. 156(4). 682–688. 22 indexed citations

Smith, P. Brian, Jennifer S. Li, M. Dianne Murphy, Robert M. Califf, & Daniel K. Benjamin. (2008). Safety of Placebo Controls in Pediatric Hypertension Trials. Hypertension. 51(4). 829–833. 9 indexed citations

10.

Benjamin, Daniel K., P. Brian Smith, Pravin Jadhav, et al.. (2008). Pediatric Antihypertensive Trial Failures. Hypertension. 51(4). 834–840. 79 indexed citations

11.

Smith, P. Brian, Daniel K. Benjamin, M. Dianne Murphy, et al.. (2008). Safety Monitoring of Drugs Receiving Pediatric Marketing Exclusivity. PEDIATRICS. 122(3). e628–e633. 26 indexed citations

12.

Li, Jennifer S., Eric L. Eisenstein, Henry G. Grabowski, et al.. (2007). Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program. JAMA. 297(5). 480–480. 114 indexed citations

13.

Benjamin, Daniel K., M. Dianne Murphy, Rosemary Roberts, et al.. (2006). Peer-Reviewed Publication of Clinical Trials Completed for Pediatric Exclusivity. JAMA. 296(10). 1266–1266. 106 indexed citations

14.

Murphy, M. Dianne, et al.. (2006). Giant traumatic pseudoaneurysm of the superficial temporal artery: Treatment challenges and case review. British Journal of Neurosurgery. 20(3). 159–161. 15 indexed citations

15.

Martone, W. J., W. W. Williams, Mary Lund Mortensen, et al.. (1986). Illness With Fatalities in Premature Infants: Association With an Intravenous Vitamin E Preparation, E-Ferol. PEDIATRICS. 78(4). 591–600. 26 indexed citations

16.

Lorch, Vichien, et al.. (1985). Unusual Syndrome Among Premature Infants: Association With a New Intravenous Vitamin E Product. PEDIATRICS. 75(3). 598–602. 37 indexed citations

17.

Murphy, M. Dianne, et al.. (1984). Effect of Early Immunization on Antibody Response to Reimmunization with Measles Vaccine as Demonstrated by Enzyme-Linked Immunosorbent Assay (ELISA). PEDIATRICS. 74(1). 90–93. 26 indexed citations

18.

Murphy, M. Dianne. (1983). Office laboratory diagnosis of sexually transmitted diseases. The Pediatric Infectious Disease Journal. 2(2). 146–152. 4 indexed citations

19.

Murphy, M. Dianne, et al.. (1983). Evaluation of the Pertussis Components of Diphtheria-Tetanus-Pertussis Vaccine. PEDIATRICS. 71(2). 200–205. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact